Suggestions
Dana Marshall
President and CEO at BacterioScan Inc.
Dana Marshall is an accomplished professional currently serving as the Chief Executive Officer and President of BacterioScan, Inc., a position he has held since December 2011.2 He is known for his strategic vision, operational acumen, and innovation in developing technology-driven product lines and businesses.
Marshall has a strong background in engineering, holding a BSE in Naval Architecture from the University of Michigan.2 Throughout his career, he has demonstrated expertise in various industries, including medical devices, optics, lasers, and precision instrumentation, with over thirty US patents to his name.
At BacterioScan, Marshall leads the company in developing and manufacturing the only FDA-cleared screening diagnostic for Urinary Tract Infection (UTI).2 This rapid point-of-care screen enables doctors to correct and de-escalate empiric antibiotics, helping to reduce the spread of antimicrobial resistance.2
Career Highlights
- Serial Entrepreneur: Marshall has a successful history of creating electro-optic products and building tech startups.1
- Leadership Roles: Prior to BacterioScan, he held significant positions such as:
- Independent Director at FluoretiQ Limited (2021-2022)2
- Chief Officer at Specific Diagnostics (2019-2020)2
- Chairman, President & CEO at Applied Energetics, Inc. (2006-2009)2
- Vice President of Optics at Zygo Corporation (2004-2006)2
- Founder, CEO, President, and Chairman at Cutting Edge Optronics, Inc. (1992-2000)2
Expertise
Marshall's expertise lies in navigating dynamic markets, driving organizational growth, and leading through transitions. His experience spans clinical, aerospace, defense, research, and precision manufacturing markets, making him a well-rounded professional with a proven track record of success in various industries.2
Highlights
400 million UTIs per year, and BacterioScan has the only FDA-cleared diagnostic for rapid point of care screening for UTI bacteruria. Learn more at
Drug resistant UTI is an urgent and difficult challenge, and demands serious action.
I'm pleased and proud to be leading BacterioScan in our campaign to bring rapid and affordable UTI screening to the point-of-care as a powerful new tool in the fight against drug resistant infections. BacterioScan delivers 99% screening accuracy for de-escalation of antibiotics before the second dose.
https://lnkd.in/gaPiNddA
